Home FDA

Revival Health Inc. Announces 9 Mil FDA EUA Authorized COVID-19 Rapid At-home Tests

Available December 2021

Revival Health Inc. (Revival), a leading global medical device manufacturer, announced the availability of over 9 million units per month of the EUA authorized COVID-19 rapid at-home tests. The company has stepped up production to produce over 9 million tests in December, 10 million in January and up to 20 million in February. The COVID-19 Antigen Home Test provides:

  • Easy and Affordable
  • Highly Accurate Nasal Swab Test
  • Quick Results in 15 minutes
  • Safe for children as young as 2 years old
  • For use with and without symptoms

The COVID-19 Antigen Home Test is a simple nasal swab test which will be available for purchase without prescription.  The test is authorized for self-testing by individuals aged 14 years and older, or with adult-collected nasal swabs from children as young as 2 years old.  Uniquely, the test is authorized for use as a single test with or without symptoms in contrast to other home tests which require two tests within a two-to-three-day period.

“We are investing heavily and pulling out all the stops to get Americans maximum protection as we face this new Omicron COVID variant through the holiday season. It is our mission to make healthcare more affordable, accessible, and easy to use. Our development and investments in COVID-19 testing moves us one step closer to this achievement,” states Jenny Yang, Chief Revenue Officer at Revival Health.

The test will be available for shipping as soon as December 20, 2021.

Exit mobile version